Finance

Beta
Lists
PEG:CPH
Pharma Equity Group A/S
DKK 0.068
-6.32%
(-0.0046) 1D
Jun 4, 5:00:00 PM GMT+2  ·   DKK
All symbols
SymbolPriceChange% Change
Generating top insights for PEG...
Open
DKK 0.07
High
DKK 0.07
Low
DKK 0.07
Mkt. cap
89.37M
Avg. vol.
896.22K
Volume
289.12K
52-wk high
DKK 0.15
52-wk low
DKK 0.06
Shares outstanding
1.23B
No. of employees
5
Open
DKK 0.07
High
DKK 0.07
Low
DKK 0.07
Mkt. cap
89.37M
Avg. vol.
896.22K
Volume
289.12K
52-wk high
DKK 0.15
52-wk low
DKK 0.06
Shares outstanding
1.23B
No. of employees
5
News stories
From sources across the web
About Pharma Equity Group A/S
CEOChristian Tange
Employees5
FoundedSep 20, 2002
Headquarters-
SectorPharmaceutical industry
Websitepharmaequitygroup.com
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in DKK
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.36M
1.36M
1.20M
1.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.28M
2.92M
3.10M
3.10M
Operating expense
4.28M
4.28M
8.36M
4.30M
Total operating expenses
4.28M
4.28M
8.36M
4.30M
Operating income
-4.28M
-4.28M
-8.36M
-8.36M
Other non operating income
500.00
500.00
-3.35M
-3.35M
EBT including unusual items
-5.00M
-5.00M
-8.21M
-8.21M
EBT excluding unusual items
-5.00M
-5.00M
-8.21M
-8.21M
Income tax expense
-250.50K
-250.50K
-266.00K
-266.00K
Effective tax rate
5.01%
5.01%
3.24%
3.24%
Other operating expenses
-
-
-
-
Net income
-4.75M
-4.75M
-7.94M
-7.94M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
4.50K
4.50K
-
-
Interest expense
-719.00K
-719.00K
-558.00K
-558.00K
Net interest expenses
-714.50K
-714.50K
-558.00K
-558.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.22M
-4.22M
-4.28M
-4.30M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer